OTC Pain

MADRID — The latest published evidence on osteoarthritis treatment was presented Wednesday at the symposium organized by Bioiberica and IBSA at the Annual European Congress of Rheumatology, here.

A new clinical trial, carried out by IBSA and called CONCEPT (ChONdroitin vs CElecoxib vs Placebo Trial), shows that pharmaceutical grade chondroitin sulfate is as effective as an anti-inflammatory drug (celecoxib) and superior to placebo for pain reduction and improvement of functional disability in patients with knee osteoarthritis.

In April, Drug Store News and Mack Elevation co-hosted the third annual New General Market Summit. The one-day thought leadership event examined the changing face of the American shopper — driven not only by the growth of multicultural and millennial consumers but also by the influence these consumers are having on all consumers — and how the best brands are able to connect on an emotional level, as well as build community and advocacy with an ever-more diverse consumer.

SOLON, Ohio and SAN FRANCISCO — Efficient Collaborative Retail Marketing has acquired a technology company that has been changing how retailers discover new suppliers.

The company on Tuesday announced the acquisition of RangeMe, which streamlines new product discovery in a way that ECRM said will complement the foundation it has laid in helping buyers discover new products and improve category planning effectiveness.

CARLSBAD, Calif.— Oska Pulse, a wearable electromagnetic field device that eases pain, was recently named "Best Product" at the 27th Annual ING Spring Conference, an annual gathering of media and golf industry executives conducted by the non-profit networking organization, the International Network of Golf.

BALTIMORE — Vizuri Consumer Healthcare on Tuesday launched PainBloc24, a 24-hour over-the-counter topical pain reliever for arthritis joint pain. PainBloc24 has been clinically shown to help relieve pain with as little as one application per day, the company stated.

CARLSBAD, Calif. — Oska Wellness on Tuesday announced the celebration of its one-year anniversary in the U.S. market with a $50 discount of its Oska Pulse wearable pain reliever. On April 12, 2016, Oska Wellness launched its flagship product, Oska Pulse, a small, portable, hands-free device that employs Pulsed Electromagnetic Field (PEMF) therapeutic technology.

WHIPPANY, N.J.— Bayer last week announced its decision to reformulate certain Alka-Seltzer effervescent products to remove the pain reliever, and related indications, in order to focus exclusively on occasional heartburn and upset stomach relief. 

"The reformulation is based on the consumer trend moving toward single indication products [treating] upset stomach and heartburn," Andre Schmidt, U.S. medical affairs VP for Bayer Consumer Health, told Drug Store News, and not over any concerns of safety, he added.